If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Search Tips:- A product is required in combination with specific keywords in order to retrieve scientific content
- Refer to Our Medications to ensure correct spelling of the product you are looking for
- Please note that keywords are required to be entered in English
- Use exact words rather than broad terms
The Therapeutic Goods Administration (TGA) has granted Comirnaty® (tozinameran) COVID-19 Vaccine provisional approval for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations.
COMIRNATY®(tozinameran)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Search Tips:- A product is required in combination with specific keywords in order to retrieve scientific content
- Refer to Our Medications to ensure correct spelling of the product you are looking for
- Please note that keywords are required to be entered in English
- Use exact words rather than broad terms
COMIRNATY® Quick Finder
*9AM-5PM (AEST) Monday to Friday
Connect with Pfizer Medical Information regarding your medical question.